Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
3D Systems | DDD | Jul 25, 2024 | 3.99 | +3.64 |
3M | MMM | Jul 25, 2024 | 103.39 | +0.14 |
4D Molecular Therapeutics | FDMT | Jul 25, 2024 | 18.52 | +3.23 |
51Talk Online Education Group ADR | COE | Jul 25, 2024 | 18.53 | +1.81 |
5E Advanced Materials | FEAM | Jul 25, 2024 | 0.97 | -4.89 |
60 Degrees Pharmaceuticals | SXTP | Jul 25, 2024 | 0.19 | +6.40 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Jul 25, 2024 | 14.03 | -0.18 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Jul 25, 2024 | 25.59 | +0.59 |
7-10 Yr Trsy Ishares | IEF | Jul 25, 2024 | 94.56 | +0.22 |
89bio | ETNB | Jul 25, 2024 | 9.66 | +7.33 |
8x8 | EGHT | Jul 25, 2024 | 3.29 | +8.94 |
908 Devices | MASS | Jul 25, 2024 | 5.55 | +3.16 |
99 Acquisition Group | NNAG | Jul 25, 2024 | 10.54 | -0.19 |
99 Acquisition Group | NNAGU | Jul 25, 2024 | 10.76 | 0.00 |
9F ADR | JFU | Jul 25, 2024 | 1.81 | -2.16 |
A SPAC I Acquisition Unit | ASCAU | Jul 25, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Jul 25, 2024 | 11.25 | -0.09 |
A-Mark Precious Metals | AMRK | Jul 25, 2024 | 36.62 | -1.53 |
a.k.a Brands | AKA | Jul 25, 2024 | 15.62 | +9.92 |
A.O Smith | AOS | Jul 25, 2024 | 82.18 | +1.76 |
A10 Networks | ATEN | Jul 25, 2024 | 14.11 | +2.25 |
A2Z Smart Technologies | AZ | Jul 25, 2024 | 0.73 | +0.08 |
AAA - A Rated Corporate Bond Ishares | QLTA | Jul 25, 2024 | 47.22 | +0.23 |
Aadi Bioscience | AADI | Jul 25, 2024 | 1.61 | +2.55 |
AAON | AAON | Jul 25, 2024 | 85.41 | +0.74 |
AAR | AIR | Jul 25, 2024 | 66.28 | +1.07 |
Abacus Life | ABL | Jul 25, 2024 | 10.07 | -5.71 |
Abbott Laboratories | ABT | Jul 25, 2024 | 105.96 | -1.21 |
AbbVie | ABBV | Jul 25, 2024 | 182.17 | +3.38 |
AbCellera Biologics | ABCL | Jul 25, 2024 | 3.10 | +2.99 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.